Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for American Healthcare REIT, Inc. (NYSE: AHR), a healthcare-focused real estate investment trust. As an issuer with common stock registered under Section 12(b) of the Securities Exchange Act of 1934, American Healthcare REIT files current reports on Form 8-K and other documents that disclose material events, financial results, capital markets transactions, governance matters and distribution declarations.
In its Form 8-K filings, the company reports quarterly earnings releases and supplemental financial data, including metrics such as GAAP net income attributable to controlling interest, Normalized Funds from Operations (NFFO) per diluted share and Same-Store Net Operating Income (NOI) growth by segment. Filings also describe acquisition and development activity across its integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties and senior housing operating properties (SHOP) segments, as well as lease buyouts and dispositions of non-core properties.
American Healthcare REIT’s SEC filings further detail capital markets activity, such as public offerings of common stock on a forward basis, at-the-market (ATM) equity offering programs and related underwriting and forward sale agreements. The company discloses how it intends to contribute net proceeds to its operating partnership for general corporate purposes, including potential future investments. Additional filings report on quarterly cash distributions authorized by the board of directors, annual meeting voting results, equity plans and corporate responsibility reporting.
On Stock Titan, AI-powered tools can help interpret these filings by summarizing key terms, highlighting segment-level performance disclosures and clarifying the implications of equity offerings, distributions and governance actions. This allows readers to review American Healthcare REIT, Inc.’s regulatory history and understand how the company describes its financial condition, portfolio management and capital structure in official SEC documents.
American Healthcare REIT, Inc. (AHR) reported rising operating revenue and a return to quarterly profit driven by resident fees. Total revenues were $542,503,000 for the three months ended June 30, 2025, up from $504,581,000 a year earlier; resident fees and services increased to $501,285,000. Net income for the quarter was $10,079,000 versus $2,926,000 in Q2 2024, producing basic earnings per share of $0.06 versus $0.01. Cash and cash equivalents rose to $133,494,000 and combined cash, cash equivalents and restricted cash were $169,991,000 at period end. The company recorded impairment charges of $12,659,000 in the quarter and $34,365,000 year-to-date related to certain outpatient medical buildings. Mortgage debt outstanding was $983,510,000 and borrowings under the 2024 Credit Facility totaled $550,000,000 (approximately $549,632,000 net). During the period AHR completed property acquisitions and dispositions, issued common equity under ATM and follow-on programs, and declared distributions totaling $0.50 per share for the six months.
American Healthcare REIT, Inc. entered into an at-the-market (ATM) equity offering sales agreement that allows the company to offer and sell up to $1.0 billion of its common stock through a group of major investment banks acting as agents or, if applicable, as forward sellers or purchasers. The agreement replaces the prior ATM program, which had no remaining unsold shares, and permits sales in negotiated block trades, ordinary brokers' transactions at prevailing market prices, on exchanges, or through electronic networks.
The agents may earn commissions up to 2.0% of gross sales price, and the company may also sell shares directly to agents as principals or enter into forward sale agreements with specified forward purchasers. Forward sale mechanics include daily interest-rate-based adjustments and decreases for expected dividends; the company will not receive proceeds from shares borrowed and sold by a Forward Purchaser. Net proceeds are expected to be contributed to the registrant's Operating Partnership for general corporate purposes, including debt repayment, working capital, capital expenditures, and potential investments.
American Healthcare REIT (NYSE:AHR) filed a Form 4 reporting a routine insider transaction. Director Marvin R. O'Quinn was granted 3,042 shares of restricted common stock on June 25, 2025 upon his re-election to the board. The grant carries a cost basis of $0 and is scheduled to vest on June 25, 2026. Following the award, O'Quinn’s beneficial ownership increases to 18,062 shares. No shares were sold or disposed of, and the filing does not reference a Rule 10b5-1 trading plan. The disclosure represents typical board compensation and does not indicate any material change in insider sentiment or the company’s financial condition.
American Healthcare REIT, Inc. (AHR) – Form 4 insider update
On 25 Jun 2025, director Mathieu B. Streiff received 3,042 restricted common shares at $0.00 as part of his re-election compensation. These shares will vest on 25 Jun 2026. After the grant, Streiff’s direct holdings rise to 32,377 shares, while he also indirectly controls 157,402 shares through the Streiff Family Trust, bringing total reported beneficial ownership to roughly 189,779 shares.
No sales, option exercises, or derivative positions were disclosed, and the filing reflects routine board compensation rather than a market transaction. The event marginally increases insider ownership but is unlikely to affect AHR’s share float, liquidity, or near-term valuation.
Form 4 overview: On June 25, 2025, American Healthcare REIT, Inc. (ticker AHR) granted Director Wilbur H. Smith III an equity award of 3,042 shares of restricted common stock in conjunction with his re-election to the board.
Key transaction terms:
- Type: Equity grant (restricted stock); reported as an “A” (acquired) transaction code.
- Price: $0 per share, indicating a non-cash, board-approved compensation grant.
- Vesting: Shares vest in full on June 25, 2026, creating a one-year lock-in that aligns director incentives with shareholder value over the next 12 months.
Ownership impact: Following the award, Smith’s total beneficial ownership increased to 32,419 common shares. The grant adds approximately 3,000 shares, modestly expanding his stake and signalling continued board-level alignment with the company’s long-term performance.
Materiality: The filing represents routine director compensation and does not disclose any open-market purchases or sales, option exercises, or derivative activity. No earnings data, financial guidance, or strategic transactions are included in this report.
American Healthcare REIT, Inc. (AHR) filed a Form 4 disclosing that director Valerie Richardson received an equity grant on 25 June 2025.
- Transaction: 3,042 shares of restricted common stock were awarded (coded “A”) at a price of $0.
- Vesting schedule: The shares vest in full on 25 June 2026.
- Post-transaction ownership: Richardson now beneficially owns 18,062 common shares, held directly.
The filing reflects routine board compensation rather than an open-market purchase. While it slightly increases insider ownership, the size of the award is modest and does not materially change overall share count or insider control.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Dianne Hurley received 3,042 restricted shares of AHR common stock on 25 Jun 2025 upon her re-election to the board. The grant was recorded at $0 cost and will vest on 25 Jun 2026. Following this award, Hurley’s direct beneficial ownership increased to 31,443 shares. No shares were sold or transferred, and no derivative securities were involved. The transaction was coded “A,” indicating a stock award rather than an open-market purchase or sale.
The filing reflects routine board compensation, resulting in minor dilution and a modest increase in insider ownership.
American Healthcare REIT, Inc. (AHR) – Form 4 insider filing
Director Brian J. Flornes reported the receipt of 3,042 shares of restricted common stock on 25 June 2025 following his re-election to the board. The grant was recorded under transaction code “A” (acquisition) at an assigned price of $0.00, indicating a non-cash equity award rather than an open-market purchase.
The awarded shares will vest on 25 June 2026, one year after the grant date. After the transaction, Mr. Flornes’ total direct beneficial ownership increased to 30,426 common shares. No derivative securities, dispositions, or sales were reported.
This filing represents a routine director compensation grant and does not introduce new debt, equity financing, or earnings guidance. The transaction adds a modest 0.003% to AHR’s outstanding share count (based on ~100 million shares outstanding, if unchanged), limiting any dilution concerns. From a governance perspective, incremental ownership can further align the director’s incentives with shareholder interests.